In just 3 months, Im down to 153.3 pounds
Following a consultation with a licensed healthcare provider on the platform, if appropriate, Hims & Hers customers will receive personalized treatment plans that include: Medication Management: Access to clinically-trusted medications that have been studied extensively and prescribed for decades
Patients who meet eligibility criteria can potentially access the medication before approval through trial participation
Who is the Ideal Candidate for QR678 Neo Treatment
Key findings include: Dose-dependent improvements in neurological function scores at doses 2.5 ml/kg in rat models Reduced infarct volumes in middle cerebral artery occlusion (MCAO) models Enhanced functional recovery when combined with rehabilitation protocols Protection against excitotoxicity and oxidative stress in acute phase Studies using embolic stroke models showed that Cerebrolysin at 5 ml/kg significantly reduced lesion volume and improved sensorimotor outcomes when treatment began 4 hours post-stroke[8]
Furthermore, the precise formulation gives them accuracy, repeatability, and consistent performance with every use